Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Sanara MedTech Inc. (SMTI) had Revenue of $25.83M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$25.83M
Net Income	$-2.01M
Cost of Goods Sold	$1.94M
Gross Profit	$23.89M
Operating Expenses	$25.86M
Operating Income	$-0.03M
Non-Operating Income/Expense	$-1.99M
Pre-Tax Income	$-2.02M
Normalized Pre-Tax Income	$-2.02M
Income after Taxes	$-2.02M
Income from Continuous Operations	$-2.02M
Consolidated Net Income/Loss	$-2.02M
Normalized Income after Taxes	$-2.02M
EBIT	$-0.03M
EBITDA	$1.16M
Weighted-Average Shares Outstanding (Basic)	8.61M
Weighted-Average Shares Outstanding (Diluted)	8.61M
Earnings per Share (EPS) (Basic)	$-0.23
Earnings per Share (EPS) (Diluted)	$-0.23
Balance Sheet Financials
Current Assets	$33.67M
Property, Plant, and Equipment	$8.90M
Long-Term Assets	$65.10M
Total Assets	$98.77M
Current Liabilities	$14.88M
Long-Term Debt	$44.22M
Long-Term Liabilities	$48.50M
Total Liabilities	$63.38M
Common Equity	$35.39M
Tangible Shareholders Equity	$-9.20M
Shareholders Equity	$35.39M
Common Shares Outstanding	8.90M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$0.67M
Cash Flow from Investing Activities	$-9.11M
Cash Flow from Financial Activities	$9.52M
Beginning Cash	$15.88M
End Cash	$16.96M
Increase/Decrease in Cash	$1.08M
Stock-Based Compensation	$2.74M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.26
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.56
Debt to Equity Ratio	1.25
Gross Margin	92.50%
Operating Margin	-0.12%
EBIT Margin	-0.12%
EBITDA Margin	--
Pre-Tax Profit Margin	-7.81%
Profit Margin	-7.80%
Free Cash Flow	$-2.76M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.26
Inventory Turnover	0.55
Receiveable Turnover	2.15
Days Sales in Receivables	41.81
Return on Equity	-5.70%
Return on Tangible Equity	21.93%
Return on Assets	-2.04%
Return on Investments	-2.54%
Book Value Per Share	$3.97
Free Cash Flow per Share	$-0.32
Operating Cash Flow per Share	$0.08

Data from Zacks Investment Research, Inc.